Jill’s Story: Advocating for Patients with Acromegaly
March 6, 2024
Jill Sisco isn’t just an advocate – she’s also a patient herself. She’s been living with Acromegaly, a rare disease that causes an overproduction of growth hormones, since 2005. In our latest video, Jill talks about all the ways Anovo has helped those in her community remove the burden of living with a rare disease, from stopping medication delays before they happen to reducing anxiety around communicating with physicians.
“Anovo is a company that always does the right thing for patients.”
Related Posts

How Anovo Builds Dedicated Teams to Support Your Rare Disease Therapy
At Anovo, we understand that complex rare disease therapies require high-touch service that large payer- and Pharmacy Benefit Manager-owned Specialty…
January 30, 2025

Justin’s Story: Living with Duchenne Muscular Dystrophy
When Justin was first diagnosed with Duchenne muscular dystrophy, his parents, Amanda and Andrew, weren’t sure how to navigate the…
January 14, 2025

Eton Pharmaceuticals & Anovo Partner to Expand Access for Patients with Severe Primary Insulin-Like Growth Factor 1 Deficiency
Eton Pharmaceuticals is dedicated to developing and commercializing treatments for rare diseases, with a strong focus on pediatric endocrinology. Their…
December 20, 2024